Covid-19 Impact on Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Status and Forecast 2020-2026
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cancer Immunotherapy Drug Discovery Outsourcing market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cancer Immunotherapy Drug Discovery Outsourcing industry.
Based on our recent survey, we have several different scenarios about the Cancer Immunotherapy Drug Discovery Outsourcing YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cancer Immunotherapy Drug Discovery Outsourcing will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Immunotherapy Drug Discovery Outsourcing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Immunotherapy Drug Discovery Outsourcing market in terms of revenue.
Players, stakeholders, and other participants in the global Cancer Immunotherapy Drug Discovery Outsourcing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Cancer Immunotherapy Drug Discovery Outsourcing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Cancer Immunotherapy Drug Discovery Outsourcing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Immunotherapy Drug Discovery Outsourcing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Immunotherapy Drug Discovery Outsourcing market.
The following players are covered in this report:
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Cancer Immunotherapy Drug Discovery Outsourcing industry.
Based on our recent survey, we have several different scenarios about the Cancer Immunotherapy Drug Discovery Outsourcing YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Cancer Immunotherapy Drug Discovery Outsourcing will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Immunotherapy Drug Discovery Outsourcing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Immunotherapy Drug Discovery Outsourcing market in terms of revenue.
Players, stakeholders, and other participants in the global Cancer Immunotherapy Drug Discovery Outsourcing market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Cancer Immunotherapy Drug Discovery Outsourcing market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Cancer Immunotherapy Drug Discovery Outsourcing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Immunotherapy Drug Discovery Outsourcing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Immunotherapy Drug Discovery Outsourcing market.
The following players are covered in this report:
- Aquila BioMedical
- BPS Bioscience, Inc.
- Celentyx Ltd
- Crown Bioscience, Inc.
- DiscoverX Corporation
- Explicyte
- Genscript Biotech Corporation
- HD Biosciences Co.
- Horizon Discovery Group PLC
- ImmunXperts SA
- Molecular Imaging, Inc.
- Promega Corporation,Personalis, Inc.
- STC Biologics
- By Drug Type
- By Cancer Type
- Lung
- Breast
- Colorectal
- Melanoma
- Prostate
- Head and Neck
- Ovarian
- Pancreatic
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
1.4 Market Analysis by Type
1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type: 2020 VS 2026
1.5 Market by Application
1.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2020 VS 2026
1.5.2 Lung
1.5.3 Breast
1.5.4 Colorectal
1.5.5 Melanoma
1.5.6 Prostate
1.5.7 Head and Neck
1.5.8 Ovarian
1.5.9 Pancreatic
1.6 Coronavirus Disease 2019 (Covid-19): Cancer Immunotherapy Drug Discovery Outsourcing Industry Impact
1.6.1 How the Covid-19 is Affecting the Cancer Immunotherapy Drug Discovery Outsourcing Industry
1.6.1.1 Cancer Immunotherapy Drug Discovery Outsourcing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cancer Immunotherapy Drug Discovery Outsourcing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cancer Immunotherapy Drug Discovery Outsourcing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2015-2026)
2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Regions
2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Immunotherapy Drug Discovery Outsourcing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Market Size
3.1.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue (2015-2020)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio
3.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2019
3.3 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
3.4 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
3.5 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2015-2020)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2021-2026)
5 CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
6.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in North America (2019-2020)
6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
7.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Europe (2019-2020)
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
8 CHINA
8.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
8.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in China (2019-2020)
8.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
8.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
9.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Japan (2019-2020)
9.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
9.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
10.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
11 INDIA
11.1 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
11.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in India (2019-2020)
11.3 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
11.4 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
12.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
12.4 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Aquila BioMedical
13.1.1 Aquila BioMedical Company Details
13.1.2 Aquila BioMedical Business Overview and Its Total Revenue
13.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020))
13.1.5 Aquila BioMedical Recent Development
13.2 BPS Bioscience, Inc.
13.2.1 BPS Bioscience, Inc. Company Details
13.2.2 BPS Bioscience, Inc. Business Overview and Its Total Revenue
13.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.2.5 BPS Bioscience, Inc. Recent Development
13.3 Celentyx Ltd
13.3.1 Celentyx Ltd Company Details
13.3.2 Celentyx Ltd Business Overview and Its Total Revenue
13.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.3.5 Celentyx Ltd Recent Development
13.4 Crown Bioscience, Inc.
13.4.1 Crown Bioscience, Inc. Company Details
13.4.2 Crown Bioscience, Inc. Business Overview and Its Total Revenue
13.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.4.5 Crown Bioscience, Inc. Recent Development
13.5 DiscoverX Corporation
13.5.1 DiscoverX Corporation Company Details
13.5.2 DiscoverX Corporation Business Overview and Its Total Revenue
13.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.5.5 DiscoverX Corporation Recent Development
13.6 Explicyte
13.6.1 Explicyte Company Details
13.6.2 Explicyte Business Overview and Its Total Revenue
13.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.6.5 Explicyte Recent Development
13.7 Genscript Biotech Corporation
13.7.1 Genscript Biotech Corporation Company Details
13.7.2 Genscript Biotech Corporation Business Overview and Its Total Revenue
13.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.7.5 Genscript Biotech Corporation Recent Development
13.8 HD Biosciences Co.
13.8.1 HD Biosciences Co. Company Details
13.8.2 HD Biosciences Co. Business Overview and Its Total Revenue
13.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.8.5 HD Biosciences Co. Recent Development
13.9 Horizon Discovery Group PLC
13.9.1 Horizon Discovery Group PLC Company Details
13.9.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue
13.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.9.5 Horizon Discovery Group PLC Recent Development
13.10 ImmunXperts SA
13.10.1 ImmunXperts SA Company Details
13.10.2 ImmunXperts SA Business Overview and Its Total Revenue
13.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.10.5 ImmunXperts SA Recent Development
13.11 Molecular Imaging, Inc.
10.11.1 Molecular Imaging, Inc. Company Details
10.11.2 Molecular Imaging, Inc. Business Overview and Its Total Revenue
10.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
10.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
10.11.5 Molecular Imaging, Inc. Recent Development
13.12 Promega Corporation,Personalis, Inc.
10.12.1 Promega Corporation,Personalis, Inc. Company Details
10.12.2 Promega Corporation,Personalis, Inc. Business Overview and Its Total Revenue
10.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
10.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
10.12.5 Promega Corporation,Personalis, Inc. Recent Development
13.13 STC Biologics
10.13.1 STC Biologics Company Details
10.13.2 STC Biologics Business Overview and Its Total Revenue
10.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction
10.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
10.13.5 STC Biologics Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
1.4 Market Analysis by Type
1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type: 2020 VS 2026
1.5 Market by Application
1.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2020 VS 2026
1.5.2 Lung
1.5.3 Breast
1.5.4 Colorectal
1.5.5 Melanoma
1.5.6 Prostate
1.5.7 Head and Neck
1.5.8 Ovarian
1.5.9 Pancreatic
1.6 Coronavirus Disease 2019 (Covid-19): Cancer Immunotherapy Drug Discovery Outsourcing Industry Impact
1.6.1 How the Covid-19 is Affecting the Cancer Immunotherapy Drug Discovery Outsourcing Industry
1.6.1.1 Cancer Immunotherapy Drug Discovery Outsourcing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cancer Immunotherapy Drug Discovery Outsourcing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cancer Immunotherapy Drug Discovery Outsourcing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2015-2026)
2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Regions
2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Immunotherapy Drug Discovery Outsourcing Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Market Size
3.1.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue (2015-2020)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio
3.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2019
3.3 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
3.4 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
3.5 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2015-2020)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2021-2026)
5 CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
6.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in North America (2019-2020)
6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
7.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Europe (2019-2020)
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
8 CHINA
8.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
8.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in China (2019-2020)
8.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
8.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
9.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Japan (2019-2020)
9.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
9.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
10.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
11 INDIA
11.1 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
11.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in India (2019-2020)
11.3 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
11.4 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2015-2020)
12.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020)
12.4 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Aquila BioMedical
13.1.1 Aquila BioMedical Company Details
13.1.2 Aquila BioMedical Business Overview and Its Total Revenue
13.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020))
13.1.5 Aquila BioMedical Recent Development
13.2 BPS Bioscience, Inc.
13.2.1 BPS Bioscience, Inc. Company Details
13.2.2 BPS Bioscience, Inc. Business Overview and Its Total Revenue
13.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.2.5 BPS Bioscience, Inc. Recent Development
13.3 Celentyx Ltd
13.3.1 Celentyx Ltd Company Details
13.3.2 Celentyx Ltd Business Overview and Its Total Revenue
13.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.3.5 Celentyx Ltd Recent Development
13.4 Crown Bioscience, Inc.
13.4.1 Crown Bioscience, Inc. Company Details
13.4.2 Crown Bioscience, Inc. Business Overview and Its Total Revenue
13.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.4.5 Crown Bioscience, Inc. Recent Development
13.5 DiscoverX Corporation
13.5.1 DiscoverX Corporation Company Details
13.5.2 DiscoverX Corporation Business Overview and Its Total Revenue
13.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.5.5 DiscoverX Corporation Recent Development
13.6 Explicyte
13.6.1 Explicyte Company Details
13.6.2 Explicyte Business Overview and Its Total Revenue
13.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.6.5 Explicyte Recent Development
13.7 Genscript Biotech Corporation
13.7.1 Genscript Biotech Corporation Company Details
13.7.2 Genscript Biotech Corporation Business Overview and Its Total Revenue
13.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.7.5 Genscript Biotech Corporation Recent Development
13.8 HD Biosciences Co.
13.8.1 HD Biosciences Co. Company Details
13.8.2 HD Biosciences Co. Business Overview and Its Total Revenue
13.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.8.5 HD Biosciences Co. Recent Development
13.9 Horizon Discovery Group PLC
13.9.1 Horizon Discovery Group PLC Company Details
13.9.2 Horizon Discovery Group PLC Business Overview and Its Total Revenue
13.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.9.5 Horizon Discovery Group PLC Recent Development
13.10 ImmunXperts SA
13.10.1 ImmunXperts SA Company Details
13.10.2 ImmunXperts SA Business Overview and Its Total Revenue
13.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction
13.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
13.10.5 ImmunXperts SA Recent Development
13.11 Molecular Imaging, Inc.
10.11.1 Molecular Imaging, Inc. Company Details
10.11.2 Molecular Imaging, Inc. Business Overview and Its Total Revenue
10.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
10.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
10.11.5 Molecular Imaging, Inc. Recent Development
13.12 Promega Corporation,Personalis, Inc.
10.12.1 Promega Corporation,Personalis, Inc. Company Details
10.12.2 Promega Corporation,Personalis, Inc. Business Overview and Its Total Revenue
10.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
10.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
10.12.5 Promega Corporation,Personalis, Inc. Recent Development
13.13 STC Biologics
10.13.1 STC Biologics Company Details
10.13.2 STC Biologics Business Overview and Its Total Revenue
10.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction
10.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
10.13.5 STC Biologics Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Cancer Immunotherapy Drug Discovery Outsourcing Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
Table 3. Ranking of Global Top Cancer Immunotherapy Drug Discovery Outsourcing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. COVID-19 Impact Global Market: (Four Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast Scenarios)
Table 6. Opportunities and Trends for Cancer Immunotherapy Drug Discovery Outsourcing Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Cancer Immunotherapy Drug Discovery Outsourcing Players to Combat Covid-19 Impact
Table 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2015-2020)
Table 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Strategy
Table 20. Main Points Interviewed from Key Cancer Immunotherapy Drug Discovery Outsourcing Players
Table 21. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2015-2020) (Million US$)
Table 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players (2015-2020)
Table 23. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2019)
Table 24. Global Cancer Immunotherapy Drug Discovery Outsourcing by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
Table 27. Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 30. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Type (2015-2020)
Table 31. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2021-2026)
Table 32. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Application (2015-2020)
Table 33. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 34. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Application (2021-2026)
Table 35. North America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 37. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 38. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 39. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 40. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 41. Europe Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 43. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 45. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 47. China Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 48. China Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 49. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 50. China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 51. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 52. China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 53. Japan Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 55. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 57. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 61. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 63. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 65. India Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 66. India Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 67. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 68. India Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 69. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 70. India Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 73. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 75. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 77. Aquila BioMedical Company Details
Table 78. Aquila BioMedical Business Overview
Table 79. Aquila BioMedical Product
Table 80. Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 81. Aquila BioMedical Recent Development
Table 82. BPS Bioscience, Inc. Company Details
Table 83. BPS Bioscience, Inc. Business Overview
Table 84. BPS Bioscience, Inc. Product
Table 85. BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 86. BPS Bioscience, Inc. Recent Development
Table 87. Celentyx Ltd Company Details
Table 88. Celentyx Ltd Business Overview
Table 89. Celentyx Ltd Product
Table 90. Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 91. Celentyx Ltd Recent Development
Table 92. Crown Bioscience, Inc. Company Details
Table 93. Crown Bioscience, Inc. Business Overview
Table 94. Crown Bioscience, Inc. Product
Table 95. Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 96. Crown Bioscience, Inc. Recent Development
Table 97. DiscoverX Corporation Company Details
Table 98. DiscoverX Corporation Business Overview
Table 99. DiscoverX Corporation Product
Table 100. DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 101. DiscoverX Corporation Recent Development
Table 102. Explicyte Company Details
Table 103. Explicyte Business Overview
Table 104. Explicyte Product
Table 105. Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 106. Explicyte Recent Development
Table 107. Genscript Biotech Corporation Company Details
Table 108. Genscript Biotech Corporation Business Overview
Table 109. Genscript Biotech Corporation Product
Table 110. Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 111. Genscript Biotech Corporation Recent Development
Table 112. HD Biosciences Co. Business Overview
Table 113. HD Biosciences Co. Product
Table 114. HD Biosciences Co. Company Details
Table 115. HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 116. HD Biosciences Co. Recent Development
Table 117. Horizon Discovery Group PLC Company Details
Table 118. Horizon Discovery Group PLC Business Overview
Table 119. Horizon Discovery Group PLC Product
Table 120. Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 121. Horizon Discovery Group PLC Recent Development
Table 122. ImmunXperts SA Company Details
Table 123. ImmunXperts SA Business Overview
Table 124. ImmunXperts SA Product
Table 125. ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 126. ImmunXperts SA Recent Development
Table 127. Molecular Imaging, Inc. Company Details
Table 128. Molecular Imaging, Inc. Business Overview
Table 129. Molecular Imaging, Inc. Product
Table 130. Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 131. Molecular Imaging, Inc. Recent Development
Table 132. Promega Corporation,Personalis, Inc. Company Details
Table 133. Promega Corporation,Personalis, Inc. Business Overview
Table 134. Promega Corporation,Personalis, Inc. Product
Table 135. Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 136. Promega Corporation,Personalis, Inc. Recent Development
Table 137. STC Biologics Company Details
Table 138. STC Biologics Business Overview
Table 139. STC Biologics Product
Table 140. STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 141. STC Biologics Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
Table 1. Cancer Immunotherapy Drug Discovery Outsourcing Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
Table 3. Ranking of Global Top Cancer Immunotherapy Drug Discovery Outsourcing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. COVID-19 Impact Global Market: (Four Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast Scenarios)
Table 6. Opportunities and Trends for Cancer Immunotherapy Drug Discovery Outsourcing Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Cancer Immunotherapy Drug Discovery Outsourcing Players to Combat Covid-19 Impact
Table 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2015-2020)
Table 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Strategy
Table 20. Main Points Interviewed from Key Cancer Immunotherapy Drug Discovery Outsourcing Players
Table 21. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2015-2020) (Million US$)
Table 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players (2015-2020)
Table 23. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2019)
Table 24. Global Cancer Immunotherapy Drug Discovery Outsourcing by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
Table 27. Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 30. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Type (2015-2020)
Table 31. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2021-2026)
Table 32. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Application (2015-2020)
Table 33. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 34. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Application (2021-2026)
Table 35. North America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 37. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 38. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 39. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 40. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 41. Europe Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 43. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 45. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 47. China Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 48. China Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 49. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 50. China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 51. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 52. China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 53. Japan Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 55. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 57. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 61. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 63. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 65. India Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 66. India Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 67. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 68. India Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 69. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 70. India Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Cancer Immunotherapy Drug Discovery Outsourcing Market Share (2019-2020)
Table 73. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2015-2020)
Table 75. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2015-2020)
Table 77. Aquila BioMedical Company Details
Table 78. Aquila BioMedical Business Overview
Table 79. Aquila BioMedical Product
Table 80. Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 81. Aquila BioMedical Recent Development
Table 82. BPS Bioscience, Inc. Company Details
Table 83. BPS Bioscience, Inc. Business Overview
Table 84. BPS Bioscience, Inc. Product
Table 85. BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 86. BPS Bioscience, Inc. Recent Development
Table 87. Celentyx Ltd Company Details
Table 88. Celentyx Ltd Business Overview
Table 89. Celentyx Ltd Product
Table 90. Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 91. Celentyx Ltd Recent Development
Table 92. Crown Bioscience, Inc. Company Details
Table 93. Crown Bioscience, Inc. Business Overview
Table 94. Crown Bioscience, Inc. Product
Table 95. Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 96. Crown Bioscience, Inc. Recent Development
Table 97. DiscoverX Corporation Company Details
Table 98. DiscoverX Corporation Business Overview
Table 99. DiscoverX Corporation Product
Table 100. DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 101. DiscoverX Corporation Recent Development
Table 102. Explicyte Company Details
Table 103. Explicyte Business Overview
Table 104. Explicyte Product
Table 105. Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 106. Explicyte Recent Development
Table 107. Genscript Biotech Corporation Company Details
Table 108. Genscript Biotech Corporation Business Overview
Table 109. Genscript Biotech Corporation Product
Table 110. Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 111. Genscript Biotech Corporation Recent Development
Table 112. HD Biosciences Co. Business Overview
Table 113. HD Biosciences Co. Product
Table 114. HD Biosciences Co. Company Details
Table 115. HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 116. HD Biosciences Co. Recent Development
Table 117. Horizon Discovery Group PLC Company Details
Table 118. Horizon Discovery Group PLC Business Overview
Table 119. Horizon Discovery Group PLC Product
Table 120. Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 121. Horizon Discovery Group PLC Recent Development
Table 122. ImmunXperts SA Company Details
Table 123. ImmunXperts SA Business Overview
Table 124. ImmunXperts SA Product
Table 125. ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 126. ImmunXperts SA Recent Development
Table 127. Molecular Imaging, Inc. Company Details
Table 128. Molecular Imaging, Inc. Business Overview
Table 129. Molecular Imaging, Inc. Product
Table 130. Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 131. Molecular Imaging, Inc. Recent Development
Table 132. Promega Corporation,Personalis, Inc. Company Details
Table 133. Promega Corporation,Personalis, Inc. Business Overview
Table 134. Promega Corporation,Personalis, Inc. Product
Table 135. Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 136. Promega Corporation,Personalis, Inc. Recent Development
Table 137. STC Biologics Company Details
Table 138. STC Biologics Business Overview
Table 139. STC Biologics Product
Table 140. STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020) (Million US$)
Table 141. STC Biologics Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type: 2020 VS 2026
Figure 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2020 VS 2026
Figure 5. Lung Case Studies
Figure 6. Breast Case Studies
Figure 7. Colorectal Case Studies
Figure 8. Melanoma Case Studies
Figure 9. Prostate Case Studies
Figure 10. Head and Neck Case Studies
Figure 11. Ovarian Case Studies
Figure 12. Pancreatic Case Studies
Figure 13. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered
Figure 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions: 2020 VS 2026
Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players in 2019
Figure 19. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2019
Figure 21. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Aquila BioMedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Aquila BioMedical Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 30. BPS Bioscience, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. BPS Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 32. Celentyx Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Celentyx Ltd Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 34. Crown Bioscience, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Crown Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 36. DiscoverX Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. DiscoverX Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 38. Explicyte Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Explicyte Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 40. Genscript Biotech Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Genscript Biotech Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 42. HD Biosciences Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. HD Biosciences Co. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 44. Horizon Discovery Group PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Horizon Discovery Group PLC Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 46. ImmunXperts SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ImmunXperts SA Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 48. Molecular Imaging, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Molecular Imaging, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 50. Promega Corporation,Personalis, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Promega Corporation,Personalis, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 52. STC Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. STC Biologics Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type: 2020 VS 2026
Figure 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2020 VS 2026
Figure 5. Lung Case Studies
Figure 6. Breast Case Studies
Figure 7. Colorectal Case Studies
Figure 8. Melanoma Case Studies
Figure 9. Prostate Case Studies
Figure 10. Head and Neck Case Studies
Figure 11. Ovarian Case Studies
Figure 12. Pancreatic Case Studies
Figure 13. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered
Figure 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions: 2020 VS 2026
Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players in 2019
Figure 19. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2019
Figure 21. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Aquila BioMedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Aquila BioMedical Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 30. BPS Bioscience, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. BPS Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 32. Celentyx Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Celentyx Ltd Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 34. Crown Bioscience, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Crown Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 36. DiscoverX Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. DiscoverX Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 38. Explicyte Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Explicyte Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 40. Genscript Biotech Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Genscript Biotech Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 42. HD Biosciences Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. HD Biosciences Co. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 44. Horizon Discovery Group PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Horizon Discovery Group PLC Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 46. ImmunXperts SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ImmunXperts SA Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 48. Molecular Imaging, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Molecular Imaging, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 50. Promega Corporation,Personalis, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Promega Corporation,Personalis, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 52. STC Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. STC Biologics Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
